The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between circulating tumor DNA (ctDNA) detection and radiographic tumor burden (rTB) in advanced bladder and upper tract (UT) cancer patients.
 
Manuel C. Maia
No Relationships to Disclose
 
Lorena Almeida
No Relationships to Disclose
 
Nazli Dizman
No Relationships to Disclose
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Veracyte
Research Funding - Guardant Health
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology